Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Prevalence and determinants of undernutrition among children under 5-year-old in rural areas: A cross-sectional survey in North Sudan.

Sulaiman AA, Bushara SO, Elmadhoun WM, Noor SK, Abdelkarim M, Aldeen IN, Osman MM, Almobarak AO, Awadalla H, Ahmed MH.

J Family Med Prim Care. 2018 Jan-Feb;7(1):104-110. doi: 10.4103/jfmpc.jfmpc_73_17.

2.

PRDM16 Gene Polymorphism Is Associated with Obesity and Blood Lipids Profiles in Saudi Population.

AlAmrani A, AbdelKarim M, AlZoghaibi M.

J Clin Med. 2018 Jun 8;7(6). pii: E141. doi: 10.3390/jcm7060141.

3.

The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemia.

Yalcin A, Kovarbasic M, Wehrle J, Claus R, Becker H, Abdelkarim M, Gaidzik VI, Schmidts A, Wäsch R, Pahl HL, Döhner K, Bullinger L, Duyster J, Lübbert M, Hackanson B.

Exp Hematol. 2017 Nov;55:76-85.e3. doi: 10.1016/j.exphem.2017.07.009. Epub 2017 Jul 28.

PMID:
28760688
4.

Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy.

Hiller JK, Schmoor C, Gaidzik VI, Schmidt-Salzmann C, Yalcin A, Abdelkarim M, Blagitko-Dorfs N, Döhner K, Bullinger L, Duyster J, Lübbert M, Hackanson B.

Ann Hematol. 2017 Apr;96(4):559-565. doi: 10.1007/s00277-016-2912-7. Epub 2017 Jan 5.

PMID:
28058491
5.

The supramammillary nucleus and the claustrum activate the cortex during REM sleep.

Renouard L, Billwiller F, Ogawa K, Clément O, Camargo N, Abdelkarim M, Gay N, Scoté-Blachon C, Touré R, Libourel PA, Ravassard P, Salvert D, Peyron C, Claustrat B, Léger L, Salin P, Malleret G, Fort P, Luppi PH.

Sci Adv. 2015 Apr 3;1(3):e1400177. doi: 10.1126/sciadv.1400177. eCollection 2015 Apr.

6.

MDA-MB-231 breast cancer cells overexpressing single VEGF isoforms display distinct colonisation characteristics.

Di Benedetto M, Toullec A, Buteau-Lozano H, Abdelkarim M, Vacher S, Velasco G, Christofari M, Pocard M, Bieche I, Perrot-Applanat M.

Br J Cancer. 2015 Sep 1;113(5):773-85. doi: 10.1038/bjc.2015.267. Epub 2015 Jul 21.

7.

Consumers' perceptions on the contribution of community pharmacists in the dispensing process at Dawadmi.

Alotaibi HS, Abdelkarim MA.

Saudi Pharm J. 2015 Jul;23(3):230-4. doi: 10.1016/j.jsps.2014.11.002. Epub 2014 Nov 20.

8.

Comprehensive molecular characterization of human adipocytes reveals a transient brown phenotype.

Guennoun A, Kazantzis M, Thomas R, Wabitsch M, Tews D, Seetharama Sastry K, Abdelkarim M, Zilberfarb V, Strosberg AD, Chouchane L.

J Transl Med. 2015 Apr 30;13:135. doi: 10.1186/s12967-015-0480-6.

9.

Tracing the development of acute myeloid leukemia in CBL syndrome.

Becker H, Yoshida K, Blagitko-Dorfs N, Claus R, Pantic M, Abdelkarim M, Niemöller C, Greil C, Hackanson B, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Döhner K, Schnittger S, Henneke P, Niemeyer CM, Flotho C, Pfeifer D, Ogawa S, Lübbert M.

Blood. 2014 Mar 20;123(12):1883-6. doi: 10.1182/blood-2013-10-533844. Epub 2014 Feb 3.

10.

Poly-cyclodextrin functionalized porous bioceramics for local chemotherapy and anticancer bone reconstruction.

Chai F, Abdelkarim M, Laurent T, Tabary N, Degoutin S, Simon N, Peters F, Blanchemain N, Martel B, Hildebrand HF.

J Biomed Mater Res B Appl Biomater. 2014 Aug;102(6):1130-9. doi: 10.1002/jbm.b.33094. Epub 2013 Dec 18.

PMID:
24347296
11.

Epigenetic priming of AML blasts for all-trans retinoic acid-induced differentiation by the HDAC class-I selective inhibitor entinostat.

Blagitko-Dorfs N, Jiang Y, Duque-Afonso J, Hiller J, Yalcin A, Greve G, Abdelkarim M, Hackanson B, Lübbert M.

PLoS One. 2013 Oct 8;8(10):e75258. doi: 10.1371/journal.pone.0075258. eCollection 2013.

12.

ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamics.

Molina A, Velot L, Ghouinem L, Abdelkarim M, Bouchet BP, Luissint AC, Bouhlel I, Morel M, Sapharikas E, Di Tommaso A, Honoré S, Braguer D, Gruel N, Vincent-Salomon A, Delattre O, Sigal-Zafrani B, André F, Terris B, Akhmanova A, Di Benedetto M, Nahmias C, Rodrigues-Ferreira S.

Cancer Res. 2013 May 1;73(9):2905-15. doi: 10.1158/0008-5472.CAN-12-3565. Epub 2013 Feb 8.

13.

MeDIP coupled with a promoter tiling array as a platform to investigate global DNA methylation patterns in AML cells.

Yalcin A, Kreutz C, Pfeifer D, Abdelkarim M, Klaus G, Timmer J, Lübbert M, Hackanson B.

Leuk Res. 2013 Jan;37(1):102-11. doi: 10.1016/j.leukres.2012.09.014. Epub 2012 Oct 11.

PMID:
23062266
14.

Transcriptome analysis and in vivo activity of fluvastatin versus zoledronic acid in a murine breast cancer metastasis model.

Vintonenko N, Jais JP, Kassis N, Abdelkarim M, Perret GY, Lecouvey M, Crepin M, Di Benedetto M.

Mol Pharmacol. 2012 Sep;82(3):521-8. doi: 10.1124/mol.111.077248. Epub 2012 Jun 20.

PMID:
22723339
15.

PAZ6 cells constitute a representative model for human brown pre-adipocytes.

Kazantzis M, Takahashi V, Hinkle J, Kota S, Zilberfarb V, Issad T, Abdelkarim M, Chouchane L, Strosberg AD.

Front Endocrinol (Lausanne). 2012 Feb 2;3:13. doi: 10.3389/fendo.2012.00013. eCollection 2012.

16.

Angiotensin II facilitates breast cancer cell migration and metastasis.

Rodrigues-Ferreira S, Abdelkarim M, Dillenburg-Pilla P, Luissint AC, di-Tommaso A, Deshayes F, Pontes CL, Molina A, Cagnard N, Letourneur F, Morel M, Reis RI, Casarini DE, Terris B, Couraud PO, Costa-Neto CM, Di Benedetto M, Nahmias C.

PLoS One. 2012;7(4):e35667. doi: 10.1371/journal.pone.0035667. Epub 2012 Apr 20.

17.

HDAC6 as a target for antileukemic drugs in acute myeloid leukemia.

Hackanson B, Rimmele L, Benkißer M, Abdelkarim M, Fliegauf M, Jung M, Lübbert M.

Leuk Res. 2012 Aug;36(8):1055-62. doi: 10.1016/j.leukres.2012.02.026. Epub 2012 Mar 29.

PMID:
22464548
18.

High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysis.

El-Sherif A, Elbahrawy A, Aboelfotoh A, Abdelkarim M, Saied Mohammad AG, Abdallah AM, Mostafa S, Elmestikawy A, Elwassief A, Salah M, Abdelbaseer MA, Abdelwahab KS.

Hemodial Int. 2012 Jul;16(3):420-7. doi: 10.1111/j.1542-4758.2011.00662.x. Epub 2012 Feb 23.

PMID:
22360424
19.

Invading basement membrane matrix is sufficient for MDA-MB-231 breast cancer cells to develop a stable in vivo metastatic phenotype.

Abdelkarim M, Vintonenko N, Starzec A, Robles A, Aubert J, Martin ML, Mourah S, Podgorniak MP, Rodrigues-Ferreira S, Nahmias C, Couraud PO, Doliger C, Sainte-Catherine O, Peyri N, Chen L, Mariau J, Etienne M, Perret GY, Crepin M, Poyet JL, Khatib AM, Di Benedetto M.

PLoS One. 2011;6(8):e23334. doi: 10.1371/journal.pone.0023334. Epub 2011 Aug 15.

20.

Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity.

Prawitt J, Abdelkarim M, Stroeve JH, Popescu I, Duez H, Velagapudi VR, Dumont J, Bouchaert E, van Dijk TH, Lucas A, Dorchies E, Daoudi M, Lestavel S, Gonzalez FJ, Oresic M, Cariou B, Kuipers F, Caron S, Staels B.

Diabetes. 2011 Jul;60(7):1861-71. doi: 10.2337/db11-0030. Epub 2011 May 18.

21.

The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1/ETO.

Duque-Afonso J, Yalcin A, Berg T, Abdelkarim M, Heidenreich O, Lübbert M.

Oncogene. 2011 Jul 7;30(27):3062-72. doi: 10.1038/onc.2011.32. Epub 2011 May 16.

PMID:
21577204
22.

The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways.

Abdelkarim M, Caron S, Duhem C, Prawitt J, Dumont J, Lucas A, Bouchaert E, Briand O, Brozek J, Kuipers F, Fievet C, Cariou B, Staels B.

J Biol Chem. 2010 Nov 19;285(47):36759-67. doi: 10.1074/jbc.M110.166231. Epub 2010 Sep 17.

23.

Noninvasive quantitative evaluation of coronary artery stent patency using 64-row multidetector computed tomography.

Abdelkarim MJ, Ahmadi N, Gopal A, Hamirani Y, Karlsberg RP, Budoff MJ.

J Cardiovasc Comput Tomogr. 2010 Jan-Feb;4(1):29-37. doi: 10.1016/j.jcct.2009.10.014. Epub 2009 Nov 27.

PMID:
20159625
24.

NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cells.

Hackanson B, Abdelkarim M, Jansen JH, Lübbert M.

Leukemia. 2010 Apr;24(4):860-1. doi: 10.1038/leu.2009.291. Epub 2010 Jan 21. No abstract available.

PMID:
20090777
25.

USE of pseudomonas stutzeri and candida utilis in the improvement of the conditions of artemia culture and protection against pathogens.

Abdelkarim M, Kamel C, Fathi K, Amina B.

Braz J Microbiol. 2010 Jan;41(1):107-15. doi: 10.1590/S1517-838220100001000017. Epub 2010 Mar 1.

26.

Inhibition of adipocyte differentiation by RORalpha.

Duez H, Duhem C, Laitinen S, Patole PS, Abdelkarim M, Bois-Joyeux B, Danan JL, Staels B.

FEBS Lett. 2009 Jun 18;583(12):2031-6. doi: 10.1016/j.febslet.2009.05.019. Epub 2009 May 18.

27.

New symmetrically esterified m-bromobenzyl non-aminobisphosphonates inhibited breast cancer growth and metastases.

Abdelkarim M, Guenin E, Sainte-Catherine O, Vintonenko N, Peyri N, Perret GY, Crepin M, Khatib AM, Lecouvey M, Di Benedetto M.

PLoS One. 2009;4(3):e4685. doi: 10.1371/journal.pone.0004685. Epub 2009 Mar 5.

28.

In vivo gene delivery in the mouse lung with lactosylated polyethylenimine, questioning the relevance of in vitro experiments.

Grosse S, Thévenot G, Aron Y, Duverger E, Abdelkarim M, Roche AC, Monsigny M, Fajac I.

J Control Release. 2008 Dec 8;132(2):105-12. doi: 10.1016/j.jconrel.2008.08.018. Epub 2008 Sep 4.

PMID:
18801395
29.

FXR-deficiency confers increased susceptibility to torpor.

Cariou B, Bouchaert E, Abdelkarim M, Dumont J, Caron S, Fruchart JC, Burcelin R, Kuipers F, Staels B.

FEBS Lett. 2007 Nov 13;581(27):5191-8. Epub 2007 Oct 12.

30.

Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines.

Berg T, Guo Y, Abdelkarim M, Fliegauf M, Lübbert M.

Leuk Res. 2007 Apr;31(4):497-506. Epub 2006 Oct 20.

PMID:
17056112
31.

AngioJet Rheolytic thrombectomy during rescue PCI for failed thrombolysis: a single-center experience.

Sherev DA, Shavelle DM, Abdelkarim M, Shook T, Mayeda GS, Burstein S, Matthews RV.

J Invasive Cardiol. 2006 Jul;18 Suppl C:12C-16C.

PMID:
16883026
32.

The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.

Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk TH, Grefhorst A, Abdelkarim M, Caron S, Torpier G, Fruchart JC, Gonzalez FJ, Kuipers F, Staels B.

J Biol Chem. 2006 Apr 21;281(16):11039-49. Epub 2006 Jan 30.

33.

Rescue percutaneous coronary intervention for failed thrombolysis.

Shavelle DM, Salami A, Abdelkarim M, French WJ, Shook TL, Mayeda GS, Burstein S, Matthews RV.

Catheter Cardiovasc Interv. 2006 Feb;67(2):214-20.

PMID:
16408298
34.

Effects of 5-aza-2'-deoxycytidine on proliferation, differentiation and p15/INK4b regulation of human hematopoietic progenitor cells.

Guo Y, Engelhardt M, Wider D, Abdelkarim M, Lübbert M.

Leukemia. 2006 Jan;20(1):115-21.

PMID:
16307025
35.

Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.

Al-Saran K, Mirza K, Al-Ghanam G, Abdelkarim M.

Pediatr Nephrol. 2006 Feb;21(2):201-5. Epub 2005 Oct 13.

PMID:
16222548
36.

Demonstration of the presence of IL-16, IL-17 and IL-18 at the murine fetomaternal interface during murine pregnancy.

Ostojic S, Dubanchet S, Chaouat G, Abdelkarim M, Truyens C, Capron F.

Am J Reprod Immunol. 2003 Feb;49(2):101-12.

PMID:
12765349

Supplemental Content

Loading ...
Support Center